Sunday, May 22, 2022

Health

BioBiz: Johnson & Johnson COVID-19 Vaccine stopped; Repertoire gets $189M infusion; Agenus presents clinical data; Solo-Dex launches and more

Both the FDA and Centers for Disease Control have decided to stop administering Johnson & Johnson’s Covid-19 vaccine after reviewing data involving six reported cases of a rare and severe type of blood clot in individuals in...

Former President Obama cheers on Joe Biden on 11th Anniversary of Affordable Care Act

Today, behind some democrats led cheers, the focus shifted towards how the rescue plan will help Americans save in regards to their health care.

World’s first oral vaccine to fight the pandemic in the works

Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants.  A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...

BioBiz: Pfizer and BioN Tech says 94% effective; Biohaven Pharma slapped by FDA with Kardashian ads

Citing data from Israel, Pfizer and BioNTech said their COVID-19 vaccine was 94% effective in preventing asymptomatic infection, but their announcement lacked key details. These new data build upon and confirm previously released data from the Israel Ministry of Health...

BioBiz: Merck to aid in COVID-19 vax production; Novavax eyes FDA filing for COVID-19 vax

Pharma giant, Merck is supporting efforts to expand the manufacturing capacity and supply of COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness...

Johnson & Johnson COVID-19 vaccine wins FDA approval for emergency use

 The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the...

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths

Several recent publications have now highlighted the damaging role of proteins called extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in COVID-19 infections. In a comprehensive report published in the high impact journal CELL, of over 5,000 proteins identified as perturbed in COVID-19...

UK Study: Single dose of AstraZeneca vaccine drastically cuts COVID-19 transmission

A new study out of the United Kingdom showed that a single dose of the COVID-19 vaccine developed by Oxford University and AstraZeneca provides a high level of protection for 12 weeks. The study results support the...

More than Two-Thirds of Americans Feel More Anxious When Experiencing Any Negative Health Symptom

For many Americans, living through 2020 has caused a dramatic shift in priorities, with their health, and the health of their loved ones especially, rising to the top as the most important concern. In fact, a nationally...

BioNTech says it plans 2 billion vaccine doses

BioNTech, which developed the first COVID-19 vaccination on the market with American partner Pfizer, says it expects to produce 2 billion doses in 2021 with ramped-up manufacturing. The company said in a presentation Monday...
- Advertisement -

Latest News

Elon Musk to Acquire Twitter

Twitter, Inc. made it official, it has entered into a definitive agreement to be acquired by an...
- Advertisement -

Renters of color pay higher security deposits, more application fees

Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...

FDA investigating illnesses linked to Lucky Charms

The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal.

Inflation, war push stress to alarming levels at the two-year COVID-19 anniversary

Two years after the World Health Organization declared COVID-19 a global pandemic, inflation, money issues and the war in Ukraine have pushed...

Data published in a Lancet journal on novel COVID-19 vaccine shows it produced robust antibodies and T cells against SARS-CoV-2

A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...